Research on MDMA and Psychedelic-Assisted Therapy [ONLINE]
May 14 @ 12:00 pm - 1:00 pm
by Portland Psychotherapy
May 14th, 2021 – Research on MDMA and Psychedelic-Assisted Therapy: An Overview of the Evidence for Clinicians with Jason Luoma, Ph.D.
This presentation is for those who want to understand the breadth of the existing research on the effectiveness of psychedelic and MDMA-assisted therapy. We will review all existing placebo-controlled randomized trials, as well as open trials. Much of this presentation is based on a recent meta-analysis that this presenter published. Attendees will walk away with a broad understanding of the strength and breadth of the existing data on psychedelic assisted therapy and how it compares to other treatments.
Jason Luoma, Ph.D. is CEO of Portland Psychotherapy in Portland, OR. His research focuses on shame, self-stigma, connection, self-compassion, and the application of ACT and psychedelic-assisted therapy to shame and self-criticism. He is currently organizing a clinical of MDMA-assisted psychotherapy for social anxiety disorder that looks like it will be the first trial of psychedelic-assisted therapy in the Pacific Northwest. He also recently organized a special section on psychedelic-assisted therapy and contextual behavioral science and is publishing a meta-analysis of outcomes of psychedelic-assisted therapy. He is also an internationally recognized trainer in ACT, former chair of the ACT training committee, and past president of the Association for Contextual Behavioral Science. He has over 50 publications including co-authoring two books: Learning Acceptance and Commitment Therapy and Values in Therapy: A Clinician’s Guide to Helping Clients Explore Values, Increase Psychological Flexibility and Live a More Meaningful Life. His work on shame and compassion can be read at www.actwithcompassion.com.